Praxis Precision Medicines to Participate in Upcoming April Conferences
Provided By GlobeNewswire
Last update: Apr 3, 2025
BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences this April:
Read more at globenewswire.comNASDAQ:PRAX (6/20/2025, 2:26:54 PM)
42.85
-0.12 (-0.28%)
Find more stocks in the Stock Screener
